ATE512667T1 - Inositol-pyrophosphate zur bestimmung der exozytotischen kapazität - Google Patents

Inositol-pyrophosphate zur bestimmung der exozytotischen kapazität

Info

Publication number
ATE512667T1
ATE512667T1 AT08801778T AT08801778T ATE512667T1 AT E512667 T1 ATE512667 T1 AT E512667T1 AT 08801778 T AT08801778 T AT 08801778T AT 08801778 T AT08801778 T AT 08801778T AT E512667 T1 ATE512667 T1 AT E512667T1
Authority
AT
Austria
Prior art keywords
determining
exocytotic
capacity
inositol pyrophosphates
pyrophosphates
Prior art date
Application number
AT08801778T
Other languages
English (en)
Inventor
Per Olof Berggren
Christopher Barker
Original Assignee
Biocrine Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocrine Ab filed Critical Biocrine Ab
Application granted granted Critical
Publication of ATE512667T1 publication Critical patent/ATE512667T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/507—Pancreatic cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
AT08801778T 2007-08-31 2008-09-01 Inositol-pyrophosphate zur bestimmung der exozytotischen kapazität ATE512667T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96944307P 2007-08-31 2007-08-31
PCT/EP2008/007131 WO2009027107A1 (en) 2007-08-31 2008-09-01 Inositol pyrophosphates determine exocytotic capacity

Publications (1)

Publication Number Publication Date
ATE512667T1 true ATE512667T1 (de) 2011-07-15

Family

ID=40086437

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08801778T ATE512667T1 (de) 2007-08-31 2008-09-01 Inositol-pyrophosphate zur bestimmung der exozytotischen kapazität

Country Status (9)

Country Link
US (3) US7855049B2 (de)
EP (1) EP2197479B1 (de)
JP (1) JP5491395B2 (de)
AT (1) ATE512667T1 (de)
DK (1) DK2197479T3 (de)
ES (1) ES2368106T3 (de)
HK (1) HK1144253A1 (de)
PL (1) PL2197479T3 (de)
WO (1) WO2009027107A1 (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69032284T2 (de) 1989-03-21 1998-10-08 Vical Inc Expression von exogenen polynukleotidsequenzen in wirbeltieren
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
WO2003066087A2 (en) 2002-02-06 2003-08-14 Developgen Aktiengesellschaft Für Entwicklungsbiologische Forschung Kinases involved in the regulation of energy homeostasis
AU2003253880A1 (en) 2002-07-15 2004-02-02 Sugen, Inc. Novel kinases

Also Published As

Publication number Publication date
US7855049B2 (en) 2010-12-21
ES2368106T3 (es) 2011-11-14
PL2197479T3 (pl) 2011-11-30
WO2009027107A1 (en) 2009-03-05
EP2197479A1 (de) 2010-06-23
JP2010536909A (ja) 2010-12-02
US20090074743A1 (en) 2009-03-19
DK2197479T3 (da) 2011-08-15
JP5491395B2 (ja) 2014-05-14
US20110318325A1 (en) 2011-12-29
EP2197479B1 (de) 2011-06-15
US20110092577A1 (en) 2011-04-21
HK1144253A1 (en) 2011-02-11

Similar Documents

Publication Publication Date Title
EA200601313A1 (ru) Варианты участка f
BR112014031365A2 (pt) métodos de detectar doenças ou condições
MA32190B1 (fr) Anticorps dirigés contre l'angiopoïétine 1 et l'angiopoïétine 2 et leur utilisation
EA200970909A1 (ru) Новый антиген, ассоциированный с новообразованными сосудами опухолевых метастазов
CL2008001250S1 (es) Suela para calzado.
CL2008001251S1 (es) Suela para calzado.
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
WO2008033408A3 (en) Methods for identifying compounds that modulate cell signaling and methods employing such compounds
CL2008001247S1 (es) Suela para calzado.
TW200622950A (en) Methods of monitoring the concentration of an analyte
BRPI0919186A2 (pt) aparelhos de barbear ou depilar e cartuchos.
CL2008001249S1 (es) Suela para calzado.
BRPI0715763A2 (pt) tratamento ou prevenÇço de cÂnceres superexpressando reg4 ou kiaa0101
ATE554978T1 (de) Überwachungseinrichtung zur überwachung von systemen eines fahrzeugs
DE602004010791D1 (de) 2,5-substituiertetetrahydroisochinoline zur verwendung als 5-ht6 modulatoren
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
MX2020010947A (es) Metodos de tratamiento de enfermedad de alzheimer.
WO2007149476A3 (en) Assays for non-apoptotic cell death and uses thereof
CL2008001246S1 (es) Suela para calzado.
WO2012094580A3 (en) Compounds that modulate oxidative stress
HK1145342A1 (en) Prognosis prediction for melanoma cancer
DK1866433T3 (da) Fremgangsmåde til identifikation af LRRK-2interagerende molekyler og til rensning af LRRK2
CL2008001245S1 (es) Suela para calzado.
TW200716132A (en) Novel chemical compounds
ATE414796T1 (de) Mittel zur herstellung von leder

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2197479

Country of ref document: EP